Filed: 5/15/2026ACC: 0001819257-26-000003
📋 What this filing means
PATIENT SQUARE CAPITAL LP filed this quarterly 13F‑HR report disclosing 29 equity positions with a total reported market value of $563.61M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
29
Positions
$563.61M
Total AUM (reported)
21.90M
Total Shares
Allocation by class
SHS$226.20M40.1%
COM$148.83M26.4%
SPONSORED ADS$88.42M15.7%
COM NEW$35.97M6.4%
SPONSORED ADR$26.81M4.8%
COM PAR $.01$25.75M4.6%
COM SHS$6.26M1.1%
Portfolio Concentration
Top 3$278.77M49.5%
4–10$134.22M23.8%
11–25$137.47M24.4%
Rest$13.15M2.3%
Top 3 weight
49.5%
Top 10 weight
73.3%
Voting Authority Distribution
Total shares with voting rights: 21.93M
Sole
Full voting authority
21.93M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole29
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings29
Rows:
ROIVANT SCIENCES LTD
SOLEShares8.17M
TypeSH
Market value$226.20M
40.13%
Sole
8.17M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares36.72K
TypeSH
Market value$26.81M
4.76%
Sole
36.72K
Shared
0.00
None
0.00
INSMED INC
SOLEShares157.50K
TypeSH
Market value$25.75M
4.57%
Sole
157.50K
Shared
0.00
None
0.00
BEONE MEDICINES LTD
SOLEShares80.54K
TypeSH
Market value$23.92M
4.24%
Sole
80.54K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares596K
TypeSH
Market value$22.94M
4.07%
Sole
596K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares230K
TypeSH
Market value$21.25M
3.77%
Sole
230K
Shared
0.00
None
0.00
BELITE BIO INC
SOLEShares116.68K
TypeSH
Market value$18.60M
3.30%
Sole
116.68K
Shared
0.00
None
0.00
LEGEND BIOTECH CORP
SOLEShares990K
TypeSH
Market value$17.91M
3.18%
Sole
1M
Shared
0.00
None
0.00
NEKTAR THERAPEUTICS
SOLEShares210K
TypeSH
Market value$15.11M
2.68%
Sole
218K
Shared
0.00
None
0.00
DBV TECHNOLOGIES S A
SOLEShares693.53K
TypeSH
Market value$14.49M
2.57%
Sole
693.53K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares493K
TypeSH
Market value$13.93M
2.47%
Sole
493K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares121.25K
TypeSH
Market value$13.50M
2.40%
Sole
121.25K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares227K
TypeSH
Market value$13.20M
2.34%
Sole
227K
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares95K
TypeSH
Market value$10.84M
1.92%
Sole
95K
Shared
0.00
None
0.00
EYEPOINT INC
SOLEShares795K
TypeSH
Market value$10.25M
1.82%
Sole
795K
Shared
0.00
None
0.00
MERCK & CO INC
SOLEShares80K
TypeSH
Market value$9.62M
1.71%
Sole
85K
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares400.64K
TypeSH
Market value$9.44M
1.67%
Sole
400.64K
Shared
0.00
None
0.00
ALLOGENE THERAPEUTICS INC
SOLEShares3.45M
TypeSH
Market value$8.42M
1.49%
Sole
3.45M
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares100K
TypeSH
Market value$8.33M
1.48%
Sole
100K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares93.88K
TypeSH
Market value$7.88M
1.40%
Sole
93.88K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares200K
TypeSH
Market value$7.84M
1.39%
Sole
200K
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares1.63M
TypeSH
Market value$6.78M
1.20%
Sole
1.63M
Shared
0.00
None
0.00
DEFINIUM THERAPEUTICS INC
SOLEShares331K
TypeSH
Market value$6.26M
1.11%
Sole
340K
Shared
0.00
None
0.00
HARROW INC
SOLEShares165.21K
TypeSH
Market value$5.83M
1.03%
Sole
165.21K
Shared
0.00
None
0.00
PROTARA THERAPEUTICS INC
SOLEShares1.03M
TypeSH
Market value$5.37M
0.95%
Sole
1.03M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTDSOLE | SHS | 8.17M | SH | $226.20M 40.13% | 8.17M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 36.72K | SH | $26.81M 4.76% | 36.72K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 157.50K | SH | $25.75M 4.57% | 157.50K | 0.00 | 0.00 |
BEONE MEDICINES LTDSOLE | SPONSORED ADS | 80.54K | SH | $23.92M 4.24% | 80.54K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 596K | SH | $22.94M 4.07% | 596K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 230K | SH | $21.25M 3.77% | 230K | 0.00 | 0.00 |
BELITE BIO INCSOLE | SPONSORED ADS | 116.68K | SH | $18.60M 3.30% | 116.68K | 0.00 | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 990K | SH | $17.91M 3.18% | 1M | 0.00 | 0.00 |
NEKTAR THERAPEUTICSSOLE | COM NEW | 210K | SH | $15.11M 2.68% | 218K | 0.00 | 0.00 |
DBV TECHNOLOGIES S ASOLE | SPONSORED ADS | 693.53K | SH | $14.49M 2.57% | 693.53K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 493K | SH | $13.93M 2.47% | 493K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 121.25K | SH | $13.50M 2.40% | 121.25K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 227K | SH | $13.20M 2.34% | 227K | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 95K | SH | $10.84M 1.92% | 95K | 0.00 | 0.00 |
EYEPOINT INCSOLE | COM NEW | 795K | SH | $10.25M 1.82% | 795K | 0.00 | 0.00 |
MERCK & CO INCSOLE | COM | 80K | SH | $9.62M 1.71% | 85K | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 400.64K | SH | $9.44M 1.67% | 400.64K | 0.00 | 0.00 |
ALLOGENE THERAPEUTICS INCSOLE | COM | 3.45M | SH | $8.42M 1.49% | 3.45M | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 100K | SH | $8.33M 1.48% | 100K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 93.88K | SH | $7.88M 1.40% | 93.88K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 200K | SH | $7.84M 1.39% | 200K | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM NEW | 1.63M | SH | $6.78M 1.20% | 1.63M | 0.00 | 0.00 |
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 331K | SH | $6.26M 1.11% | 340K | 0.00 | 0.00 |
HARROW INCSOLE | COM | 165.21K | SH | $5.83M 1.03% | 165.21K | 0.00 | 0.00 |
PROTARA THERAPEUTICS INCSOLE | COM STK | 1.03M | SH | $5.37M 0.95% | 1.03M | 0.00 | 0.00 |
Page 1 of 2